In fact in these patients, as in several other primary immunodeficient (PID) patients, immunodeficiency is often accompanied by the development of autoimmune disorders [9], reported to affect 25% to 72% of patients [10]–[12], irrespectively of WASP expression levels and disease severity [12]. This evidence concerns the gene WAS and Autoimmunity.